Phase 1 of the INTERCEPT-Lynch trial, which is funded by Moderna, sponsored by the University of Oxford and run by the University's Oncology Clinical Trials Office with support from Oxford Cancer, has received authorisation from the Medicines and Healthcare products Regulatory Agency and is expected to begin recruiting participants this summer.

An event focused on advancing scientific collaboration and improving outcomes for liver cancer.

In an advance for early cancer detection, a new Oxford-led study has received £3.6 million from the National Institute of Health and Care Research to evaluate breakthrough multi-cancer tests in NHS ge...

UKRI Chief Executive outlines changes to UKRI investment approach, addressing concerns about research funding and the financial position of STFC.

Three trailblazing scientists take on cancer, changing peoples’ lives, right now

Direct trains will run from Cowley and Littlemore to Oxford and London Marylebone, as the Government today announces £120m of funding to reopen the Cowley Branch Line to passengers. The funds will pa...

Oxford Cancer is inviting volunteers from the University to provide a small blood sample to the INTEGRATOR Research Tissue Bank.

The cells could be a new source of tumor DNA for liquid biopsies

The SCAN pathway offers a unique opportunity to access one of the UK’s most comprehensive research infrastructures for non-specific cancer symptoms.

The MRC Laboratory of Medical Sciences (LMS) is a biomedical research institute where scientists and clinicians collaborate to advance the understanding of biology and its application to medicine. LMS...

Congratulations to Zinaida Dedeic, Joshua Fieggen, Ella Mi, Shizhe Xu, Yuhan Zheng and Noushin Zibandeh who have been awarded OxCODE funds to attend this year’s major cancer prevention and early detec...

Discover alternative travel solutions for Oxford and the surrounding area, from bus routes and bike paths to lift shares and route planning.

Join our webinar on 21 May to learn about this new partnership and how to apply for co-funding through the Biology to Prevention Award

An academic position as a Senior Postdoctoral Researcher in Genomics of Myeloid Disorders is being advertised on jobs.ac.uk. Click now to find more details and explore additional academic job opportun...

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message…

David’s research will focus on immune dysregulation in colorectal and endometrial pre-cancers and cancers.

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message…

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message…

Information on Patient and Public Involvement for researchers

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent ...

Global biopharma company GSK invests up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent

Oxford University researchers have unveiled a new blood test, powered by machine learning, which shows real promise in detecting multiple types of cancer in their earliest stages, when the disease is